Nav: Home

ESIB -- European Summit of Industrial Biotechnology 2016

May 23, 2016

Participants at this year's European Summit of Industrial Biotechnology (ESIB) are going to focus on "design" in biotechnology - at an event that not only covers science but also deals with industrial needs and hopes, economic challenges, funding resources or political aspirations. The ESIB will take place in the historic city of Graz in the heart of Europe from November 14th to 16th, 2016.

Hundreds of scientific conferences and dozens of partnering events and fairs are held per year. Most of them provide great platforms for scientific presentations and exchange of expertise. However, the European Summit of Industrial Biotechnology (ESIB) goes one step further. It has not been designed to be another conference or another partnering event among many others. The ESIB is a platform for industrial biotechnology in multiple contexts. It has been designed to encourage all protagonists of industrial biotechnology to think outside the box and in new and comprehensive dimensions.

This year's vision is about design - this guiding thread of the 2½ days event unites major contributors to international industrial biotechnology under one roof to learn from celebrated experts, executives, and entrepreneurs, to get new inputs from politics and funding agencies and finally to develop profitable ideas with prospective partners.

We invite you to seize the opportunity to discuss vital questions and encouraging topics and to be on top of new insights and trends at the ESIB 2016 from November 14-16 in Graz, Austria. This year's topics will cover trends in biotech science and industry, cascade design and metabolic engineering, designing nature (e.g. proteins for competitive bioprocesses), in-silico approaches in modern industrial biotechnology and much more.

The European Summit of Industrial Biotechnology 2016 is organized by acib, the Austrian Centre of Industrial Biotechnology. Find more information about the ESIB 2016 at http://www.esib.at

About acib

The Austrian Centre of Industrial Biotechnology (acib) is an international research center for industrial biotechnology with locations in Vienna, Graz, Innsbruck, Linz, Tulln, Hamburg, Heidelberg and Bielefeld (DE), Pavia (IT), Ljubljana (SI), Barcelona (ES) and Rzeszow (PL). Additionally, acib is a scientific and industrial network of 130+ partners, including 3M, G.L. Pharma, Boehringer Ingelheim, DSM, Baxalta, Lon-za, Sandoz, VTU Technology, etc.

At acib, 200+ employees work on more than 70 research projects with the final goal to replace conventional industrial processes and products by more environmentally friendly and more economical approaches. More information about acib's research can be found in acib's "Biotech Stories": goo.gl/3GBEr9

acib is owned by the University of Natural Resources and Life Sciences, Graz University of Technology, the Universities of Innsbruck and Graz and the Styrian Joanneum Research. acib is financed by industrial and public contributions. The latter come from the Austrian Research Promotion Agency of the Republic of Austria (FFG), Standortagentur Tirol, Styrian Business Promotion Agency (SFG), the province of Lower Austria and the Vienna Business Agency.

http://www.acib.at
-end-


Austrian Research Centre of Industrial Biotechnology (ACIB)

Related Biotechnology Articles:

The end of biotechnology as we know it
More than 400 attendees from five continents discussed trends and improvements in biotechnology at the European Summit of Industrial Biotechnology (ESIB) in Graz/Austria and talked many topics like a dehumanized research process.
Biotechnology: A growing field in the developing world
A detailed new report surveys a broad cross-section of biotechnology work across developing countries, revealing steady growth in fields tied to human well-being worldwide.
China releases first report on biotechnology in developing countries
The first report on biotechnology in developing countries revealing an overall picture of their biotechnology growth and competitiveness was released on Nov.
Exclusive: Biotechnology leaders surveyed about impact of Trump presidency
The day following the election of Donald J. Trump as President, a survey of leaders in biotechnology in the United States, conducted by Genetic Engineering & Biotechnology News showed that Trump's presidency will negatively impact NIH research funding as well as STEM education; a plurality said it will also spark a 'brain drain' as foreign-born researchers educated in American universities will be more likely to leave.
Novel 'repair system' discovered in algae may yield new tools for biotechnology
The algae C. reinhardtii uses a novel system for releasing an interrupting sequence from a protein -- a technique that may be useful for protein purification.
ESIB -- European Summit of Industrial Biotechnology 2016
'Design' will be the guiding thread of the 2½ days ESIB 2016 which will cover trends in biotech science and industry, cascade design and metabolic engineering, designing nature (e.g. proteins for competitive bioprocesses), in-silico approaches in modern industrial biotechnology, networking opportunities and much more.
Werner Siemens Foundation fosters synthetic biotechnology
With its donation of 11.5 million euro, the Werner Siemens Foundation has facilitated the launch of the teaching and research domain Synthetic Biotechnology at the Technical University of Munich (TUM).
Sanyal Biotechnology LLC announces strategic partnership with OWL Metabolomics, S.L.
Sanyal Biotechnology LLC and One Way Liver S.L. (OWL Metabolomics) have initiated a strategic partnership to provide increased value and additional R&D services to basic research and the pharmaceutical industry, announced at the International Liver Congress in Barcelona, Spain.
ASU researcher improves crop performance with new biotechnology
Researchers with Arizona State University's School of Life Sciences have discovered a way to enhance a plant's tolerance to stress, which in turn improves how it uses water and nutrients from the soil.
New biotechnology to inhibit microRNA activity and novel applications
Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Brad Amendt, University of Iowa, Iowa City, USA, will present a study titled 'New Biotechnology to Inhibit MicroRNA Activity and Novel Applications for Craniofacial and Dental Research.'

Related Biotechnology Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Don't Fear Math
Why do many of us hate, even fear math? Why are we convinced we're bad at it? This hour, TED speakers explore the myths we tell ourselves and how changing our approach can unlock the beauty of math. Guests include budgeting specialist Phylecia Jones, mathematician and educator Dan Finkel, math teacher Eddie Woo, educator Masha Gershman, and radio personality and eternal math nerd Adam Spencer.
Now Playing: Science for the People

#517 Life in Plastic, Not Fantastic
Our modern lives run on plastic. It's in the computers and phones we use. It's in our clothing, it wraps our food. It surrounds us every day, and when we throw it out, it's devastating for the environment. This week we air a live show we recorded at the 2019 Advancement of Science meeting in Washington, D.C., where Bethany Brookshire sat down with three plastics researchers - Christina Simkanin, Chelsea Rochman, and Jennifer Provencher - and a live audience to discuss plastics in our oceans. Where they are, where they are going, and what they carry with them. Related links:...